Save

Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne

In: Beneficial Microbes
Authors:
G. Fabbrocini Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.

Search for other papers by G. Fabbrocini in
Current site
Google Scholar
PubMed
Close
,
M. Bertona 2E Science, Via Monte Grappa, 13, 27038 Robbio (PV), Italy.

Search for other papers by M. Bertona in
Current site
Google Scholar
PubMed
Close
,
Ó. Picazo Nutriscience Education and Consulting, Avenida das Forças Armadas, 1600-082 Lisbon, Portugal.

Search for other papers by Ó. Picazo in
Current site
Google Scholar
PubMed
Close
,
H. Pareja-Galeano Universidad Europea and Research Institute i+12, Tajo s/n, Villaviciosa de Odón, 28670 Madrid, Spain.

Search for other papers by H. Pareja-Galeano in
Current site
Google Scholar
PubMed
Close
,
G. Monfrecola Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.

Search for other papers by G. Monfrecola in
Current site
Google Scholar
PubMed
Close
, and
E. Emanuele 2E Science, Via Monte Grappa, 13, 27038 Robbio (PV), Italy.

Search for other papers by E. Emanuele in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

$40.00

Systemic supplementation with probiotics is increasingly being explored as a potential treatment strategy for skin disorders. Because both the gut-skin axis and dysregulation of insulin signalling have been implicated in the pathogenesis of adult acne, we designed the current study to evaluate the effect of supplementation with the probiotic strain Lactobacillus rhamnosus SP1 (LSP1) on skin expression of genes involved in insulin signalling and acne improvement in adult subjects. A pilot, randomised, double-blinded, placebo-controlled study was conducted with 20 adult subjects (14 females and 6 males; mean age: 33.7±3.3 years) with acne. Over a 12-week period, the probiotic group (n=10) consumed a liquid supplement containing LSP1 at a dose of 3×109 cfu/day (75 mg/day), whereas the placebo group (n=10) received a liquid lacking probiotics. Paired skin biopsies – one obtained before treatment initiation and one obtained at the end of the 12-week treatment period – were analysed for insulin-like growth factor 1 (IGF1) and forkhead box protein O1 (FOXO1) gene expression. The clinical criterion for efficacy was the investigator's global improvement rating on a five-point scale. Compared with baseline, the probiotic group showed a 32% (P<0.001) reduction, as well as a 65% increase (P<0.001) in IGF1 and FOXO1 gene expression in the skin, respectively. No such differences were observed in the placebo group. Patients in the probiotic group had an adjusted odds ratio of 28.4 (95% confidence interval = 2.2-411.1, P<0.05) to be rated by physicians as improved/markedly improved (versus worsened or unchanged) compared with the placebo group. We conclude that supplementation with the probiotic strain LSP1 normalises skin expression of genes involved in insulin signalling and improves the appearance of adult acne.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 1684 1650 108
Full Text Views 45 25 3
PDF Views & Downloads 70 49 3